In the highly metastatic HSC3 subcutaneous tumor model, HOXA11-AS knockdown inhibited tumor growth by 25% more than lanthanide inhibition of ME1, a putative mediator of NQO1 (Figure 6A). Here, ME1 is linked to neoplasm.